View in EDS

Genomic landscape and molecularly informed therapy in thymic carcinoma and other advanced thymic epithelial tumors.

Saved in:
Bibliographic Details
Title: Genomic landscape and molecularly informed therapy in thymic carcinoma and other advanced thymic epithelial tumors.
Authors: Möhrmann L; Computational Health Informatics Program, Boston Children's Hospital, Harvard Medical School, Boston, USA; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany. Electronic address: lino.moehrmann@nct-dresden.de., Rostock L; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany., Werner M; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany., Oleś M; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany., Arnold JS; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany; Institute for Clinical Genetics, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany; Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany., Paramasivam N; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany., Jöhrens K; Department of Pathology, University Hospital Carl Gustav Carus, Dresden, Germany., Rupp L; Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany., Schmitz M; Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany., Richter D; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany., Uhrig S; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany., Fröhlich M; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany., Hutter B; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany., Hüllein J; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany., Jahn A; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany; Institute for Clinical Genetics, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany; Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany., Arlt M; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany; Institute for Clinical Genetics, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany; Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany., Möhrmann EE; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany., Hanf D; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany., Gieldon L; Institute of Medical Genetics, Carl von Ossietzky University, Oldenburg, Germany., Kreutzfeldt S; Division of Translational Medical Oncology, DKFZ, Heidelberg, Germany; NCT Heidelberg, Heidelberg, Germany., Heilig CE; Division of Translational Medical Oncology, DKFZ, Heidelberg, Germany; NCT Heidelberg, Heidelberg, Germany., Teleanu MV; Division of Translational Medical Oncology, DKFZ, Heidelberg, Germany; NCT Heidelberg, Heidelberg, Germany., Lipka DB; Section Translational Cancer Epigenomics, Department of Translational Medical Oncology, NCT Heidelberg and DKFZ, Heidelberg, Germany., Beck K; Institute of Medical Genetics, Carl von Ossietzky University, Oldenburg, Germany., Baude-Müller A; Division of Translational Medical Oncology, DKFZ, Heidelberg, Germany; NCT Heidelberg, Heidelberg, Germany; Section Translational Cancer Epigenomics, Department of Translational Medical Oncology, NCT Heidelberg and DKFZ, Heidelberg, Germany., Mock A; Institute of Pathology, Ludwig-Maximilians-Universität München (LMU), Munich, Germany., Jelas I; Charité Comprehensive Cancer Center, Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Rieke DT; Charité Comprehensive Cancer Center, Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Wiesweg M; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany., Brandts C; Department of Medicine, Hematology/Oncology, University Hospital, Goethe University, Frankfurt, Germany; University Cancer Center Frankfurt (UCT), University Hospital, Goethe University, Frankfurt, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany., Boerries M; Institute of Medical Bioinformatics and Systems Medicine, Medical Center-University of Freiburg, and Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany., Illert AL; Department of Internal Medicine I, Division of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Freiburg im Breisgau, Germany; Klinik und Poliklinik für Innere Medizin III, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany., Desuki A; University Cancer Center and Department of Internal Medicine III, University Medical Center Mainz, Mainz, Germany; TRON-Translational Oncology, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany; DKTK, partner site Frankfurt/Mainz, a partnership between DKFZ and University Medical Center Mainz, Mainz, Germany., Kindler T; University Cancer Center and Department of Internal Medicine III, University Medical Center Mainz, Mainz, Germany; TRON-Translational Oncology, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany; DKTK, partner site Frankfurt/Mainz, a partnership between DKFZ and University Medical Center Mainz, Mainz, Germany., Krackhardt AM; Klinik und Poliklinik für Innere Medizin III, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany., Westphalen CB; Department of Internal Medicine III, University Hospital, LMU Munich and Comprehensive Cancer Center, Munich, Germany., Christopoulos P; Department of Thoracic Oncology, Thoraxklinik, Heidelberg University Hospital, and NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany; Translational Lung Research Center, member of the German Center for Lung Research (DZL), Heidelberg, Germany., Apostolidis L; Department of Medical Oncology, NCT Heidelberg and Heidelberg University Hospital, Heidelberg, Germany., Stenzinger A; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Allgäuer M; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Neumann O; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Kerle IA; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany., Horak P; Division of Translational Medical Oncology, DKFZ, Heidelberg, Germany; NCT Heidelberg, Heidelberg, Germany., Heining C; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany., Grosch H; Department of Thoracic Oncology, Thoraxklinik, Heidelberg University Hospital, and NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany; Translational Lung Research Center, member of the German Center for Lung Research (DZL), Heidelberg, Germany., Schröck E; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany; Institute for Clinical Genetics, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany; Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany., Hübschmann D; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany; Innovation and Service Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany; Pattern Recognition and Digital Medicine Group, Heidelberg Institute for Stem cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany., Fröhling S; Division of Translational Medical Oncology, DKFZ, Heidelberg, Germany; NCT Heidelberg, Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany., Glimm H; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany; Translational Functional Cancer Genomics, DKFZ Heidelberg, Heidelberg, Germany. Electronic address: hanno.glimm@nct-dresden.de.
Source: Med (New York, N.Y.) [Med] 2025 Jun 13; Vol. 6 (6), pp. 100612. Date of Electronic Publication: 2025 Mar 18.
Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101769215 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6340 (Electronic) Linking ISSN: 26666340 NLM ISO Abbreviation: Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40107270
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Genomic landscape and molecularly informed therapy in thymic carcinoma and other advanced thymic epithelial tumors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Möhrmann+L%22">Möhrmann L</searchLink>; Computational Health Informatics Program, Boston Children's Hospital, Harvard Medical School, Boston, USA; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany. Electronic address: lino.moehrmann@nct-dresden.de.<br /><searchLink fieldCode="AU" term="%22Rostock+L%22">Rostock L</searchLink>; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany.<br /><searchLink fieldCode="AU" term="%22Werner+M%22">Werner M</searchLink>; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Oleś+M%22">Oleś M</searchLink>; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Arnold+JS%22">Arnold JS</searchLink>; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany; Institute for Clinical Genetics, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany; Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Paramasivam+N%22">Paramasivam N</searchLink>; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Jöhrens+K%22">Jöhrens K</searchLink>; Department of Pathology, University Hospital Carl Gustav Carus, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Rupp+L%22">Rupp L</searchLink>; Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Schmitz+M%22">Schmitz M</searchLink>; Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Richter+D%22">Richter D</searchLink>; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany.<br /><searchLink fieldCode="AU" term="%22Uhrig+S%22">Uhrig S</searchLink>; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Fröhlich+M%22">Fröhlich M</searchLink>; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Hutter+B%22">Hutter B</searchLink>; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Hüllein+J%22">Hüllein J</searchLink>; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Jahn+A%22">Jahn A</searchLink>; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany; Institute for Clinical Genetics, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany; Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Arlt+M%22">Arlt M</searchLink>; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany; Institute for Clinical Genetics, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany; Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Möhrmann+EE%22">Möhrmann EE</searchLink>; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Hanf+D%22">Hanf D</searchLink>; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Gieldon+L%22">Gieldon L</searchLink>; Institute of Medical Genetics, Carl von Ossietzky University, Oldenburg, Germany.<br /><searchLink fieldCode="AU" term="%22Kreutzfeldt+S%22">Kreutzfeldt S</searchLink>; Division of Translational Medical Oncology, DKFZ, Heidelberg, Germany; NCT Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Heilig+CE%22">Heilig CE</searchLink>; Division of Translational Medical Oncology, DKFZ, Heidelberg, Germany; NCT Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Teleanu+MV%22">Teleanu MV</searchLink>; Division of Translational Medical Oncology, DKFZ, Heidelberg, Germany; NCT Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Lipka+DB%22">Lipka DB</searchLink>; Section Translational Cancer Epigenomics, Department of Translational Medical Oncology, NCT Heidelberg and DKFZ, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Beck+K%22">Beck K</searchLink>; Institute of Medical Genetics, Carl von Ossietzky University, Oldenburg, Germany.<br /><searchLink fieldCode="AU" term="%22Baude-Müller+A%22">Baude-Müller A</searchLink>; Division of Translational Medical Oncology, DKFZ, Heidelberg, Germany; NCT Heidelberg, Heidelberg, Germany; Section Translational Cancer Epigenomics, Department of Translational Medical Oncology, NCT Heidelberg and DKFZ, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Mock+A%22">Mock A</searchLink>; Institute of Pathology, Ludwig-Maximilians-Universität München (LMU), Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Jelas+I%22">Jelas I</searchLink>; Charité Comprehensive Cancer Center, Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Rieke+DT%22">Rieke DT</searchLink>; Charité Comprehensive Cancer Center, Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Wiesweg+M%22">Wiesweg M</searchLink>; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Brandts+C%22">Brandts C</searchLink>; Department of Medicine, Hematology/Oncology, University Hospital, Goethe University, Frankfurt, Germany; University Cancer Center Frankfurt (UCT), University Hospital, Goethe University, Frankfurt, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Boerries+M%22">Boerries M</searchLink>; Institute of Medical Bioinformatics and Systems Medicine, Medical Center-University of Freiburg, and Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.<br /><searchLink fieldCode="AU" term="%22Illert+AL%22">Illert AL</searchLink>; Department of Internal Medicine I, Division of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Freiburg im Breisgau, Germany; Klinik und Poliklinik für Innere Medizin III, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Desuki+A%22">Desuki A</searchLink>; University Cancer Center and Department of Internal Medicine III, University Medical Center Mainz, Mainz, Germany; TRON-Translational Oncology, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany; DKTK, partner site Frankfurt/Mainz, a partnership between DKFZ and University Medical Center Mainz, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Kindler+T%22">Kindler T</searchLink>; University Cancer Center and Department of Internal Medicine III, University Medical Center Mainz, Mainz, Germany; TRON-Translational Oncology, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany; DKTK, partner site Frankfurt/Mainz, a partnership between DKFZ and University Medical Center Mainz, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Krackhardt+AM%22">Krackhardt AM</searchLink>; Klinik und Poliklinik für Innere Medizin III, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Westphalen+CB%22">Westphalen CB</searchLink>; Department of Internal Medicine III, University Hospital, LMU Munich and Comprehensive Cancer Center, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Christopoulos+P%22">Christopoulos P</searchLink>; Department of Thoracic Oncology, Thoraxklinik, Heidelberg University Hospital, and NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany; Translational Lung Research Center, member of the German Center for Lung Research (DZL), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Apostolidis+L%22">Apostolidis L</searchLink>; Department of Medical Oncology, NCT Heidelberg and Heidelberg University Hospital, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Stenzinger+A%22">Stenzinger A</searchLink>; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Allgäuer+M%22">Allgäuer M</searchLink>; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Neumann+O%22">Neumann O</searchLink>; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Kerle+IA%22">Kerle IA</searchLink>; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Horak+P%22">Horak P</searchLink>; Division of Translational Medical Oncology, DKFZ, Heidelberg, Germany; NCT Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Heining+C%22">Heining C</searchLink>; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Grosch+H%22">Grosch H</searchLink>; Department of Thoracic Oncology, Thoraxklinik, Heidelberg University Hospital, and NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany; Translational Lung Research Center, member of the German Center for Lung Research (DZL), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Schröck+E%22">Schröck E</searchLink>; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany; Institute for Clinical Genetics, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany; Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Hübschmann+D%22">Hübschmann D</searchLink>; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany; Innovation and Service Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany; Pattern Recognition and Digital Medicine Group, Heidelberg Institute for Stem cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Fröhling+S%22">Fröhling S</searchLink>; Division of Translational Medical Oncology, DKFZ, Heidelberg, Germany; NCT Heidelberg, Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Glimm+H%22">Glimm H</searchLink>; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany; Translational Functional Cancer Genomics, DKFZ Heidelberg, Heidelberg, Germany. Electronic address: hanno.glimm@nct-dresden.de.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101769215%22">Med (New York, N.Y.)</searchLink> [Med] 2025 Jun 13; Vol. 6 (6), pp. 100612. <i>Date of Electronic Publication: </i>2025 Mar 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101769215 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2666-6340 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226666340%22">26666340 </searchLink><i>NLM ISO Abbreviation: </i>Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40107270
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.medj.2025.100612
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100612
    Titles:
      – TitleFull: Genomic landscape and molecularly informed therapy in thymic carcinoma and other advanced thymic epithelial tumors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Möhrmann L
      – PersonEntity:
          Name:
            NameFull: Rostock L
      – PersonEntity:
          Name:
            NameFull: Werner M
      – PersonEntity:
          Name:
            NameFull: Oleś M
      – PersonEntity:
          Name:
            NameFull: Arnold JS
      – PersonEntity:
          Name:
            NameFull: Paramasivam N
      – PersonEntity:
          Name:
            NameFull: Jöhrens K
      – PersonEntity:
          Name:
            NameFull: Rupp L
      – PersonEntity:
          Name:
            NameFull: Schmitz M
      – PersonEntity:
          Name:
            NameFull: Richter D
      – PersonEntity:
          Name:
            NameFull: Uhrig S
      – PersonEntity:
          Name:
            NameFull: Fröhlich M
      – PersonEntity:
          Name:
            NameFull: Hutter B
      – PersonEntity:
          Name:
            NameFull: Hüllein J
      – PersonEntity:
          Name:
            NameFull: Jahn A
      – PersonEntity:
          Name:
            NameFull: Arlt M
      – PersonEntity:
          Name:
            NameFull: Möhrmann EE
      – PersonEntity:
          Name:
            NameFull: Hanf D
      – PersonEntity:
          Name:
            NameFull: Gieldon L
      – PersonEntity:
          Name:
            NameFull: Kreutzfeldt S
      – PersonEntity:
          Name:
            NameFull: Heilig CE
      – PersonEntity:
          Name:
            NameFull: Teleanu MV
      – PersonEntity:
          Name:
            NameFull: Lipka DB
      – PersonEntity:
          Name:
            NameFull: Beck K
      – PersonEntity:
          Name:
            NameFull: Baude-Müller A
      – PersonEntity:
          Name:
            NameFull: Mock A
      – PersonEntity:
          Name:
            NameFull: Jelas I
      – PersonEntity:
          Name:
            NameFull: Rieke DT
      – PersonEntity:
          Name:
            NameFull: Wiesweg M
      – PersonEntity:
          Name:
            NameFull: Brandts C
      – PersonEntity:
          Name:
            NameFull: Boerries M
      – PersonEntity:
          Name:
            NameFull: Illert AL
      – PersonEntity:
          Name:
            NameFull: Desuki A
      – PersonEntity:
          Name:
            NameFull: Kindler T
      – PersonEntity:
          Name:
            NameFull: Krackhardt AM
      – PersonEntity:
          Name:
            NameFull: Westphalen CB
      – PersonEntity:
          Name:
            NameFull: Christopoulos P
      – PersonEntity:
          Name:
            NameFull: Apostolidis L
      – PersonEntity:
          Name:
            NameFull: Stenzinger A
      – PersonEntity:
          Name:
            NameFull: Allgäuer M
      – PersonEntity:
          Name:
            NameFull: Neumann O
      – PersonEntity:
          Name:
            NameFull: Kerle IA
      – PersonEntity:
          Name:
            NameFull: Horak P
      – PersonEntity:
          Name:
            NameFull: Heining C
      – PersonEntity:
          Name:
            NameFull: Grosch H
      – PersonEntity:
          Name:
            NameFull: Schröck E
      – PersonEntity:
          Name:
            NameFull: Hübschmann D
      – PersonEntity:
          Name:
            NameFull: Fröhling S
      – PersonEntity:
          Name:
            NameFull: Glimm H
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 13
              M: 06
              Text: 2025 Jun 13
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2666-6340
          Numbering:
            – Type: volume
              Value: 6
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Med (New York, N.Y.)
              Type: main
ResultId 1